MYND Life Sciences announces debt reduction

seekingalpha
25 Nov 2024
  • MYND Life Sciences (OTCQB:MYNDF) announced removal of C$800,619.65 in loan and officer deferred salary debt and has been converted into shares of MYND Life Sciences.
  • This conversion is intended to align the interests of the company's leadership with its shareholders and to demonstrate a buy-in to MYND's vision and strategic plan.
  • The company also announced the appointment of Lana Hoogenboom to its Board of Directors. 

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10